Allergan Settles New York Opioid Case For $200M; Teva Only Defendant Left
NEW YORK — Allergan Finance LLC and its affiliates have agreed to pay $200 million to settle claims by New York and Suffolk and Nassau counties that Allergan’s marketing of prescription...To view the full article, register now.
Already a subscriber? Click here to view full article